Recording of ProfGlantz June 4 presentation “Are ecigs safer than regular cigs?” is now available

On June 4, 2004, I gave a presentation to the Clean Air Coalition of British Columbia, which includes the Heart and Stroke Foundation and the Canadian Cancer Society, entitled “Are E-Cigarettes Safer than Regular Cigarettes?” Several people asked if I a recording was available.

It is.    The link is https://us02web.zoom.us/rec/share/rz8sgGt3JyCFS-wWHJJE94ynyXkVsqNOjKUnxnrHsKJbhcTo-_MQDQUxf_Kl0PYf.E35DQkP5nljY9V95 Passcode: ?FCk!$3&

An open access version of our NEJM Evidence paper is available here and a one-page plain language summary is available here.

Overview: 
E-cigarettes are often promoted as a smoking cessation aid.  The evidence to support this claim comes from randomized controlled trials generally comparing providing e-cigarettes with nicotine replacement therapy however real-world population studies paint a different picture.  In the short run, e-cigarette use is not associated with stopping smoking and in the long run may be associated with continued smoking and dual use (using e-cigarettes and cigarettes at the same time).   Regardless of whether or not they stop smoking, smokers who use e-cigarettes are more likely to remain addicted to nicotine than smokers who do not use e-cigarettes.  In addition, based on actual disease outcomes, e-cigarettes are about as dangerous as cigarettes for cardiovascular disease, stroke and metabolic disease and only slightly less dangerous for respiratory and oral diseases.

Presenter:
Dr. Stanton Glantz was Truth Initiative Distinguished Professor of Tobacco Control and Professor of Medicine at the University of California San Francisco until he retired three years ago.  He conducts research on a wide range of topics ranging from the health effects of e-cigarettes and second-hand smoke (with particular emphasis on the cardiovascular system) to the efficacy of different tobacco control policies. As the tobacco landscape has changed, Dr. Glantz’ work has expanded to include cannabis policy, because of the interactions between tobacco and cannabis.  He is a globally recognized expert on e-cigarettes and is applying his understanding of the tobacco industry to the emerging marijuana industry as well as the sugar industry.

Published by Stanton Glantz

Stanton Glantz is a retired Professor of Medicine who served on the University of California San Francisco faculty for 45 years. He conducts research on tobacco and cannabis control and cardiovascular disease/

Leave a comment